# Association Between Organophosphate Flame Retardant Exposure and Trouble Sleeping: Integrating Epidemiological Evidence with Mechanistic Insights

**Authors:** Yifei Guo, Ke Fan, Wenhan Tang, Caoyue Wu, Xin Ni, Tianqi Ling, Linhao Zong, Fei Ma, Miao Guan

PMC · DOI: 10.3390/ijms27041934 · 2026-02-18

## TL;DR

This study finds a link between exposure to a common flame retardant and trouble sleeping, suggesting a possible environmental health risk.

## Contribution

The study integrates epidemiological data with molecular mechanisms to propose a novel pathway linking OPFRs to sleep disturbances.

## Key findings

- DBuP, a metabolite of TnBP, shows a non-linear, J-shaped relationship with trouble sleeping.
- Network analysis identified five core genes (PPARG, MMP9, PTGS2, APP, EGFR) interacting with DBuP and TnBP.
- Molecular docking and simulations suggest TnBP and DBuP bind to these genes, potentially driving inflammatory responses.

## Abstract

Trouble sleeping has become a global public health challenge. However, the relationship between organophosphate flame retardant (OPFR) exposure and trouble sleeping remains unclear. This study integrated epidemiological analysis, network toxicology, molecular docking, molecular dynamics simulations, and adverse outcome pathway (AOP) construction to identify OPFRs linked to trouble sleeping and attempted to elucidate underlying molecular mechanisms. We analyzed cross-sectional data from the U.S. National Health and Nutrition Examination Survey (NHANES 2013–2018) involving 4585 eligible adults. Logistic regression confirmed dibutyl phosphate (DBuP) as significantly correlated with trouble sleeping. Restricted cubic splines (RCSs) revealed a significant non-linear, J-shaped relationship between dibutyl phosphate (DBuP) levels and trouble sleeping. Weighted quantile sum (WQS) analysis determined that DBuP accounted for the majority contribution (58.23%) to the observed effects within exposure mixtures. These findings indicated that DBuP, a metabolite of tributyl phosphate (TnBP), was closely related to trouble sleeping, suggesting that the environmental health risks of TnBP may be jointly contributed to by itself and DBuP. We used network analysis to identify five core target genes (PPARG, MMP9, PTGS2, APP, EGFR) that interact with DBuP and its parent compound TnBP. Molecular docking predicted binding poses of TnBP and DBuP toward these five core targets; all showed moderate binding affinity (ΔG ≤ −5.0 kcal/mol) except MMP9, which exhibited weak binding. Molecular dynamics simulations further supported this putative binding. Enrichment analysis highlighted inflammatory response pathways. Ultimately, we elucidated the process from molecular exposure to trouble sleeping by constructing an AOP framework. In conclusion, we proposed that TnBP and DBuP may contribute to trouble sleeping through multi-target interactions, primarily through PPARG-driven inflammatory dysregulation. These findings suggest a potential link between OPFR exposure and trouble sleeping, providing insights that warrant further mechanistic investigation.

## Linked entities

- **Genes:** PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 5468], MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318], PTGS2 (prostaglandin-endoperoxide synthase 2) [NCBI Gene 5743], APP (amyloid beta precursor protein) [NCBI Gene 351], EGFR (epidermal growth factor receptor) [NCBI Gene 1956]
- **Chemicals:** dibutyl phosphate (PubChem CID 7881), tributyl phosphate (PubChem CID 31357), TnBP (PubChem CID 31357)

## Full-text entities

- **Genes:** IL4 (interleukin 4) [NCBI Gene 3565] {aka BCGF-1, BCGF1, BSF-1, BSF1, IL-4}, ELAVL2 (ELAV like RNA binding protein 2) [NCBI Gene 1993] {aka HEL-N1, HELN1, HUB}, ACHE (acetylcholinesterase (Yt blood group)) [NCBI Gene 43] {aka ACEE, ARACHE, N-ACHE, YT}, GLS (glutaminase) [NCBI Gene 2744] {aka AAD20, CASGID, DEE71, EIEE71, GAC, GAM}, GRB2 (growth factor receptor bound protein 2) [NCBI Gene 2885] {aka ASH, EGFRBP-GRB2, Grb3-3, MST084, MSTP084, NCKAP2}, MBP (myelin basic protein) [NCBI Gene 4155], XYLT2 (xylosyltransferase 2) [NCBI Gene 64132] {aka PXYLT2, SOS, XT-II, XT2, xylT-II}, SHC1 (SHC adaptor protein 1) [NCBI Gene 6464] {aka SHC, SHCA}, RELA (RELA proto-oncogene, NF-kB subunit) [NCBI Gene 5970] {aka AIF3BL3, CMCU, NFKB3, p65}, PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 5468] {aka CIMT1, FPLD3, GLM1, NR1C3, PPARG1, PPARG2}, IL13 (interleukin 13) [NCBI Gene 3596] {aka IL-13, P600}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}, GAP43 (growth associated protein 43) [NCBI Gene 2596] {aka B-50, GAP-43, PP46}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, APP (amyloid beta precursor protein) [NCBI Gene 351] {aka AAA, ABETA, ABPP, AD1, APPI, CTFgamma}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, PTGS2 (prostaglandin-endoperoxide synthase 2) [NCBI Gene 5743] {aka COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2}, MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318] {aka CLG4B, GELB, MANDP2, MMP-9}, SRC (SRC proto-oncogene, non-receptor tyrosine kinase) [NCBI Gene 6714] {aka ASV, SRC1, THC6, c-SRC, p60-Src}
- **Diseases:** impaired reproductive development (MESH:D002658), hyperactivity (MESH:D006948), dyssomnia (MESH:D020920), depression (MESH:D003866), impaired neuronal network (MESH:D009410), OSA (MESH:D020181), neuroinflammation (MESH:D000090862), asthma (MESH:D001249), toxicity (MESH:D064420), ADHD (MESH:D001289), tumor (MESH:D009369), insomnia (MESH:D007319), Neurotoxicity (MESH:D020258), Alzheimer's disease (MESH:D000544), mitochondrial dysfunction (MESH:D028361), AOP (MESH:D011248), lipid metabolism disorders (MESH:D052439), impaired sleep quality (MESH:D012893), hypertension (MESH:D006973), parasomnia (MESH:D020447), inflammation (MESH:D007249), injury to (MESH:D014947), neurodegeneration (MESH:D019636)
- **Chemicals:** calcium (MESH:D002118), manganese (MESH:D008345), creatinine (MESH:D003404), cadmium (MESH:D002104), GDP (MESH:D006153), Hydrogen (MESH:D006859), tributyl phosphate (MESH:C009524), lead (MESH:D007854), TBEP (MESH:C013320), DBuP (MESH:C065087), BPA (MESH:C006780), PGE2 (MESH:D015232), arachidonic acid (MESH:D016718), lipid (MESH:D008055), TCEP (MESH:C031324), carbon (MESH:D002244), TPHP (MESH:C005445), amino acid (MESH:D000596), prostaglandin (MESH:D011453), oxygen (MESH:D010100), phosphorus (MESH:D010758), TCP (MESH:D014317), BCPP (MESH:C000629391), aluminum (MESH:D000535), eicosanoid (MESH:D015777), BDCPP (MESH:C588130), Ca2+ (-), organophosphate (MESH:D010755), GTP (MESH:D006160)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090], Danio rerio (leopard danio, species) [taxon 7955]

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12940232/full.md

---
Source: https://tomesphere.com/paper/PMC12940232